Clinical Trial

VIVUS Unveils Global Initiative to Advance Healthy and Sustainable Weight Management

VIVUS reaffirms commitment to combatting global obesity crisis on World Obesity Day 2025 with VIVUS For Life CAMPBELL, Calif., March…

10 months ago

Cingulate Reports Safety Results from Final Phase 3 Trials for Lead ADHD Asset CTx-1301: On Track to File for FDA Approval Mid-2025

Results Have Been Submitted Ahead of In-Person Meeting with FDA Set for April 2 CTx-1301 is the First, True, Once-Daily…

10 months ago

ACELYRIN Determines Unsolicited Indication of Interest From Concentra Biosciences Not Reasonably Expected to Result in a Superior Proposal to Planned Alumis Merger

All-Stock Transaction with Alumis Maximizes Long-Term Value for ACELYRIN Stockholders LOS ANGELES, March 04, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC.…

10 months ago

Frontier Scientific Solutions Appoints Keith Parent as Chief Technology Officer

WILMINGTON, N.C., March 4, 2025 /PRNewswire/ -- Frontier Scientific Solutions, a leading provider of GMP temperature-controlled storage and Free Trade Zone (FTZ)…

10 months ago

HealthTree Foundation Launches AI-Powered Personalized Clinical Trial Finder

The HealthTree Clinical Trial Finder Now Matches Multiple Myeloma Patients to Eligible Clinical Trials Based on Their Medical Records SALT…

10 months ago

Unveiling Journey by Radicle Science: Latest Innovation from the Award-Winning Healthtech Pioneer

The First Health Impact Tracker for Wellness Brand Drives Adherence and 20-30% Higher Repeat Purchases in Pilots SAN DIEGO, March…

10 months ago

TransCelerate BioPharma Publishes Resources to Accelerate Industry Adoption of Newly-Released ICH E6(R3) Guidelines

New tools support sponsors in operationalizing important new guidelines to advance clinical trial conduct worldwide PHILADELPHIA, March 3, 2025 /PRNewswire/…

10 months ago

Peerbridge Health Unveils Cor MDx™ Next-Generation IoT ECG Wearable at HIMSS Global Health Conference

Wireless connectivity enablement with AT&T helps Peerbridge expand access to AI-driven cardiac care LAS VEGAS, March 3, 2025 /PRNewswire/ -- Peerbridge…

10 months ago

IDEAYA Biosciences Announces Collaboration with ATTMOS to Accelerate AI/ML-Enabled Drug Discovery for Unprecedented First-in-Class Oncology Targets

SOUTH SAN FRANCISCO, Calif., March 3, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed…

10 months ago

Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease

MALVERN, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader…

10 months ago